Hellings P W, Akdis C A, Bachert C, Bousquet J, Pugin B, Adriaensen G, Advani R, Agache I, Anjo C, Anmolsingh R, Annoni E, Bieber T, Bizaki A, Braverman I, Callebaut I, Castillo Vizuete J A, Chalermwatanachai T, Chmielewski R, Cingi C, Cools L, Coppije C, Cornet M E, De Boeck I, De Corso E, De Greve G, Doulaptsi M, Edmiston R, Erskine S, Gevaert E, Gevaert P, Golebski K, Hopkins C, Hox V, Jaeggi C, Joos G, Khwaja S, Kjeldsen A, Klimek L, Koennecke M, Kortekaas Krohn I, Krysko O, Kumar B N, Langdon C, Lange B, Lekakis G, Levie P, Lourijsen E, Lund V J, Martens K, Mő Sges R, Mullol J, Nyembue T D, Palkonen S, Philpott C, Pimentel J, Poirrier A, Pratas A C, Prokopakis E, Pujols L, Rombaux P, Schmidt-Weber C, Segboer C, Spacova I, Staikuniene J, Steelant B, Steinsvik E A, Teufelberger A, Van Gerven L, Van Gool K, Verbrugge R, Verhaeghe B, Virkkula P, Vlaminck S, Vries-Uss E, Wagenmann M, Zuberbier T, Seys S F, Fokkens W J
Department of Otorhinolaryngology-Head and Neck Surgery, UZ Leuven, Belgium.
Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Christine-Kuhne Center for Allergy Research and Education, Davos, Switzerland.
Rhinology. 2017 Sep 1;55(3):202-210. doi: 10.4193/Rhin17.028.
The first European Rhinology Research Forum organized by the European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA) was held in the Royal Academy of Medicine in Brussels on 17th and 18th November 2016, in collaboration with the European Rhinologic Society (ERS) and the Global Allergy and Asthma European Network (GA2LEN). One hundred and thirty participants (medical doctors from different specialties, researchers, as well as patients and industry representatives) from 27 countries took part in the multiple perspective discussions including brainstorming sessions on care pathways and research needs in rhinitis and rhinosinusitis. The debates started with an overview of the current state of the art, including weaknesses and strengths of the current practices, followed by the identification of essential research needs, thoroughly integrated in the context of Precision Medicine (PM), with personalized care, prediction of success of treatment, participation of the patient and prevention of disease as key principles for improving current clinical practices. This report provides a concise summary of the outcomes of the brainstorming sessions of the European Rhinology Research Forum 2016.
由欧洲过敏与气道疾病研究与教育论坛（EUFOREA）组织的首届欧洲鼻科学研究论坛，于2016年11月17日至18日在布鲁塞尔的皇家医学院举行，此次论坛与欧洲鼻科学会（ERS）以及全球过敏与哮喘欧洲网络（GA2LEN）合作举办。来自27个国家的130名参与者（包括不同专业的医生、研究人员、患者以及行业代表）参加了多角度讨论，其中包括关于鼻炎和鼻窦炎护理途径及研究需求的头脑风暴会议。讨论首先对当前的技术水平进行了概述，包括当前实践的优缺点，随后确定了基本的研究需求，并将其全面融入精准医学（PM）的背景下，以个性化护理、治疗成功预测、患者参与和疾病预防作为改善当前临床实践的关键原则。本报告简要总结了2016年欧洲鼻科学研究论坛头脑风暴会议的成果。
